Cargando…
CD19 CAR-T细胞治疗B细胞淋巴瘤22例疗效及安全性
OBJECTIVE: To investigate the efficacy and safety of CD19 chimeric antigen receptor T (CAR-T) lymphocytes for the treatment of B cell lymphoma. METHODS: A total of 22 patients with B-cell lymphoma from February 1, 2017 to July 1, 2018 were reviewed to evaluate the efficacy and adverse reactions of C...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343005/ https://www.ncbi.nlm.nih.gov/pubmed/31104437 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.003 |